Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.
J.M. Liddell, PhD
Advertisement
J.M.Liddell, PhD, is head of process science at Avecia Biologics Ltd.
Articles by J.M. Liddell, PhD
Advertisement
Latest Updated Articles
Production Strategies for Antibody Fragment TherapeuticsPublished: June 2nd 2009 | Updated:
Advertisement
Advertisement
